Pila Pharma Danmark ApS: Financial statements 2019
CVR: 39023636
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -2,366,859 and a net result of DKK -2,101,576. Equity in the 2019 report amounted to DKK 909,492. The solvency ratio was 96.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -2,366,859
- Profit/Loss
- DKK -2,101,576
- Equity
- DKK 909,492
- Total Assets
- DKK 940,335
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Pila Pharma Danmark ApS has published its interim report for the period October 18, 2017 to December 31, 2018.
As of May 27, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Pila Pharma Danmark ApS.
As of March 28, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Pila Pharma Danmark ApS.
As of March 28, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Pila Pharma Danmark ApS.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.